Literature DB >> 24909917

KITENIN-targeting microRNA-124 suppresses colorectal cancer cell motility and tumorigenesis.

So-Yeon Park1, Hangun Kim2, Somy Yoon1, Jeong A Bae1, Seok-Yong Choi1, Young Do Jung1, Kyung Keun Kim1.   

Abstract

MicroRNAs are increasingly implicated in the modulation of the progression of various cancers. We previously observed that KAI1 C-terminal interacting tetraspanin (KITENIN) is highly expressed in sporadic human colorectal cancer (CRC) tissues and hence the functional KITENIN complex acts to promote progression of CRC. However, it remains unknown that microRNAs target KITENIN and whether KITENIN-targeting microRNAs modulate CRC cell motility and colorectal tumorigenesis. Here, through bioinformatic analyses and functional studies, we showed that miR-124, miR-27a, and miR-30b negatively regulate KITENIN expression and suppress the migration and invasion of several CRC cell lines via modulation of KITENIN expression. Through in vitro and in vivo induction of mature microRNAs using a tetracycline-inducible system, miR-124 was found to effectively inhibit the invasion of CT-26 colon adenocarcinoma cells and tumor growth in a syngeneic mouse xenograft model. Constitutive overexpression of precursor miR-124 in CT-26 cells suppressed in vivo tumorigenicity and resulted in decreased expression of KITENIN as well as that of MYH9 and SOX9, which are targets of miR-124. Thus, our findings identify that KITENIN-targeting miR-124, miR-27a, and miR-30b function as endogenous inhibitors of CRC cell motility and demonstrate that miR-124 among KITENIN-targeting microRNAs plays a suppressor role in colorectal tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24909917      PMCID: PMC4435482          DOI: 10.1038/mt.2014.105

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  50 in total

1.  The miR-124-Sox9 paramutation: RNA-mediated epigenetic control of embryonic and adult growth.

Authors:  Valérie Grandjean; Pierre Gounon; Nicole Wagner; Luc Martin; Kay D Wagner; Florence Bernex; François Cuzin; Minoo Rassoulzadegan
Journal:  Development       Date:  2009-11       Impact factor: 6.868

Review 2.  Cancer regulator microRNA: potential relevance in diagnosis, prognosis and treatment of cancer.

Authors:  G Fiorucci; M V Chiantore; G Mangino; Z A Percario; E Affabris; G Romeo
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

Review 3.  Alterations of microRNAs contribute to colon carcinogenesis.

Authors:  Aaron J Schetter; Curtis C Harris
Journal:  Semin Oncol       Date:  2011-12       Impact factor: 4.929

4.  MicroRNA-124 suppresses oral squamous cell carcinoma motility by targeting ITGB1.

Authors:  Stuart Hunt; Adam V Jones; Emma E Hinsley; Simon A Whawell; Daniel W Lambert
Journal:  FEBS Lett       Date:  2010-11-27       Impact factor: 4.124

5.  Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells.

Authors:  F Yu; H Deng; H Yao; Q Liu; F Su; E Song
Journal:  Oncogene       Date:  2010-05-24       Impact factor: 9.867

6.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

7.  Downregulation of microRNA-124 is an independent prognostic factor in patients with colorectal cancer.

Authors:  Mo-Jin Wang; Yuan Li; Rui Wang; Cun Wang; Yong-Yang Yu; Lie Yang; Yi Zhang; Bin Zhou; Zong-Guang Zhou; Xiao-Feng Sun
Journal:  Int J Colorectal Dis       Date:  2012-08-11       Impact factor: 2.571

8.  MicroRNA-124 suppresses breast cancer cell growth and motility by targeting CD151.

Authors:  Zhi-Bo Han; Zhouxin Yang; Ying Chi; Lei Zhang; Youwei Wang; Yueru Ji; Jinhan Wang; Hui Zhao; Zhong Chao Han
Journal:  Cell Physiol Biochem       Date:  2013-06-04

9.  MicroRNAs in cancer treatment and prognosis.

Authors:  Cláudia Regina Gasque Schoof; Eder Leite da Silva Botelho; Alberto Izzotti; Luciana Dos Reis Vasques
Journal:  Am J Cancer Res       Date:  2012-06-28       Impact factor: 6.166

10.  KITENIN recruits Dishevelled/PKC delta to form a functional complex and controls the migration and invasiveness of colorectal cancer cells.

Authors:  D H Kho; J A Bae; J H Lee; H J Cho; S H Cho; J H Lee; Y-W Seo; K Y Ahn; I J Chung; K K Kim
Journal:  Gut       Date:  2008-07-24       Impact factor: 23.059

View more
  23 in total

1.  A peptide interfering with the dimerization of oncogenic KITENIN protein and its stability suppresses colorectal tumour progression.

Authors:  Sung Jin Kim; Eun Gene Sun; Jeong A Bae; Sehoon Park; Chang-Soo Hong; Zee-Yong Park; Hangun Kim; Kyung Keun Kim
Journal:  Clin Transl Med       Date:  2022-07

2.  Comparative effects of diet and carcinogen on microRNA expression in the stem cell niche of the mouse colonic crypt.

Authors:  Manasvi S Shah; Eunjoo Kim; Laurie A Davidson; Jason M Knight; Roger S Zoh; Jennifer S Goldsby; Evelyn S Callaway; Beyian Zhou; Ivan Ivanov; Robert S Chapkin
Journal:  Biochim Biophys Acta       Date:  2015-10-19

3.  Influence of miR-30b regulating humoral immune response by genetic difference.

Authors:  Zhi-Qing Duan; Jian-Dong Shi; Mei-Ni Wu; Ning-Zhu Hu; Yun-Zhang Hu
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

4.  Long noncoding RNA HOTAIR promotes renal cell carcinoma malignancy through alpha-2, 8-sialyltransferase 4 by sponging microRNA-124.

Authors:  Yue Pan; Yongjin Wu; Jialei Hu; Yujia Shan; Jia Ma; Huipeng Ma; Xia Qi; Li Jia
Journal:  Cell Prolif       Date:  2018-08-13       Impact factor: 6.831

5.  A new KSRP-binding compound suppresses distant metastasis of colorectal cancer by targeting the oncogenic KITENIN complex.

Authors:  Jeong A Bae; Woo Kyun Bae; Sung Jin Kim; Yoo-Seung Ko; Keon Young Kim; So-Yeon Park; Young Hyun Yu; Eun Ae Kim; Ik Joo Chung; Hangun Kim; Hyung-Ho Ha; Kyung Keun Kim
Journal:  Mol Cancer       Date:  2021-05-26       Impact factor: 27.401

6.  miRNA-target network reveals miR-124as a key miRNA contributing to clear cell renal cell carcinoma aggressive behaviour by targeting CAV1 and FLOT1.

Authors:  Henriett Butz; Peter M Szabó; Heba W Z Khella; Roy Nofech-Mozes; Attila Patocs; George M Yousef
Journal:  Oncotarget       Date:  2015-05-20

7.  KITENIN promotes glioma invasiveness and progression, associated with the induction of EMT and stemness markers.

Authors:  Kyung-Hwa Lee; Eun-Jung Ahn; Se-Jeong Oh; Ok Kim; Young-Eun Joo; Jeong-A Bae; Somy Yoon; Hyang-Hwa Ryu; Shin Jung; Kyung-Keun Kim; Jae-Hyuk Lee; Kyung-Sub Moon
Journal:  Oncotarget       Date:  2015-02-20

8.  Lichen Secondary Metabolite, Physciosporin, Inhibits Lung Cancer Cell Motility.

Authors:  Yi Yang; So-Yeon Park; Thanh Thi Nguyen; Young Hyun Yu; Tru Van Nguyen; Eun Gene Sun; Jayalal Udeni; Min-Hye Jeong; Iris Pereira; Cheol Moon; Hyung-Ho Ha; Kyung Keun Kim; Jae-Seoun Hur; Hangun Kim
Journal:  PLoS One       Date:  2015-09-15       Impact factor: 3.240

Review 9.  Tumor Suppressive Effects of miR-124 and Its Function in Neuronal Development.

Authors:  Rikako Sanuki; Tomonori Yamamura
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

10.  Identification and bioinformatics analysis of miRNAs associated with human muscle invasive bladder cancer.

Authors:  Liang Chen; Lushun Yuan; Gang Wang; Rui Cao; Jianping Peng; Bo Shu; Guofeng Qian; Xinghuan Wang; Yu Xiao
Journal:  Mol Med Rep       Date:  2017-10-04       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.